| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-5223(03)00207-1 |
| P698 | PubMed publication ID | 12878934 |
| P50 | author | Valerie W Rusch | Q51775643 |
| Steven M. Larson | Q82997710 | ||
| P2093 | author name string | Mithat Gonen | |
| Raja M Flores | |||
| Timothy Akhurst | |||
| P2860 | cites work | A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group | Q34295028 |
| Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients | Q34485292 | ||
| Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability | Q35440433 | ||
| The importance of surgical staging in the treatment of malignant pleural mesothelioma | Q40945772 | ||
| Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma | Q41745606 | ||
| A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma | Q63548148 | ||
| Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography | Q77318679 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | positron emission tomography | Q208376 |
| P304 | page(s) | 11-16 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
| P1476 | title | Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma | |
| P478 | volume | 126 |
| Q42792120 | A case of malignant pericardial mesothelioma with constrictive pericarditis physiology misdiagnosed as pericardial metastatic cancer |
| Q33812537 | A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma |
| Q36162505 | Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma |
| Q41837522 | An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on Imaging |
| Q38018217 | Asbestos-related pleuropulmonary diseases: benign and malignant |
| Q30478994 | BTS statement on malignant mesothelioma in the UK, 2007. |
| Q24644647 | Clinical consequences of asbestos-related diffuse pleural thickening: A review |
| Q37029331 | Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma |
| Q37086026 | Current concepts in malignant pleural mesothelioma. |
| Q37817035 | Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment |
| Q81042649 | Diagnosis of a malignant mesothelioma by EUS-guided FNA of a mediastinal lymph node |
| Q30371725 | Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma. |
| Q53094562 | Diagnostic Imaging and workup of Malignant Pleural Mesothelioma. |
| Q38044217 | Diffuse neoplasms of the pleural serosa. |
| Q92854234 | Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases |
| Q64248928 | Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma |
| Q42552072 | Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach |
| Q51770071 | FDG PET/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma. |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q28394028 | Guidelines for the diagnosis and treatment of malignant pleural mesothelioma |
| Q35894683 | Imaging of pleural and chest wall tumors |
| Q34616107 | Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. |
| Q41814268 | Localized biphasic type malignant mesothelioma arising in the peritoneum: Report of a case |
| Q80961479 | Malignant mesothelioma |
| Q47098675 | Malignant mesothelioma: Canadian perspective and research directions |
| Q84107270 | Malignant pleural mesothelioma |
| Q51326575 | Malignant pleural mesothelioma in a patient with systemic sclerosis: the first report. |
| Q64930781 | Malignant pleural mesothelioma: main topics of American Society of Clinical Oncology clinical practice guidelines for diagnosis and treatment. |
| Q33871571 | Malignant pleural mesothelioma: predictors and staging |
| Q35839385 | Mesothelioma: a review |
| Q84976311 | Oral presentation of malignant mesothelioma |
| Q42956963 | Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease |
| Q37426353 | Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma |
| Q53175010 | Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma. |
| Q35885165 | Radiology in pleural disease: state of the art. |
| Q34096881 | Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels |
| Q41307384 | The value of delayed phase enhanced imaging in malignant pleural mesothelioma |
| Q39211278 | Video-assisted cervical thoracoscopy: a novel approach for diagnosis, staging and pleurodesis of malignant pleural mesothelioma |
| Q53540179 | [18-Fluoro-deoxy-glucose (15FDG) positon emission tomography (PET) for the evaluation of malignant pleural disease] |
Search more.